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ABSTRACT: We report a high-performance, liquid chroma-
tography/tandem mass spectrometry (HPLC-MS/MS) assay
to quantify without derivatizaton dehyroepiandrosterone
(DHEA), 17β-estradiol (E2), testosterone (T), and their
sulfates in serum and tissues. This assay functions well with
multiple adipose depots, a previously unattained analysis. To
delipidate and facilitate recovery, tissues were homogenized in
acetonitrile, and the homogenate was frozen. The supernatant
was evaporated, resuspended in an aqueous acetate buffer, and extracted with hexane to separate free (unconjugated) from
sulfated steroids. Sulfated steroids in the aqueous medium were then hydrolyzed with sulfatase and extracted with hexane. Each
extract was analyzed separately. HPLC resolution combined with the sensitivity and specificity of MS/MS allowed
quantification of DHEA, E2, and T with 10, 10, and 5 fmol lower limits of quantification and linear ranges to 1 pmol.
Application of the method to mouse serum and tissues reveals ranges of DHEA, E2, and T and their sulfates, and tissue-specific
differences in steroid profile, especially white versus brown adipose. In addition, marginal decreases of T in all tissues and
considerable increases in DHEA in male iWAT and eWAT in response to a high-fat diet further strengthen the inference
regarding the role of steroid metabolism in adipogenesis. This assay permits detailed studies of interactions between adiposity
and sex steroids in serum and tissues, including adipose.
Steroid hormones are classified into five major groups:progestens, glucocorticoids, mineralocorticoids, androgens,
and estrogens. All are biosynthesized from cholesterol. Since
the signaling nature and therapeutic potential of steroids began
to be appreciated, dating back to the early 20th century, several
quantification methods have been developed, such as
competitive ELISA,1 radioimmunoassay,2 GC/electron capture
detection,3 and GC/mass spectrometry.4 With advances in
LC/MS, there has been a growing trend toward simultaneous
measurement of multiple steroids,5,6 necessitated by inter-
connected metabolic nets, which can be complementary or
contrasting. The application of quantitative analytical methods,
however, has been limited predominantly to urine and
serum.7,8 Sensitive assays applicable to tissues have been
elusive, because of difficulties in maintaining sensitivity for
diverse steroids, while minimizing matrix effects and interfering
peaks.
Sex steroids correlate with adiposity. Dehydroepiandroster-
one (DHEA) therapy induces statistically significant decreases
in visceral and subcutaneous pads by 13 cm2 for each fat pad.9
In men, muscle size and strength are androgen dose-
dependent, whereas fat mass is estrogen-dependent.10 Free
testosterone (T) levels are ∼50% higher in obese women
compared to nonobese women.11 In rats, estradiol (E2)
activates thermogenesis in brown adipose tissue (BAT).12
Adipose tissues serve as steroid reservoirs and sites of steroid
metabolism, which affect systemic levels. In human abdominal
subcutaneous fat, 17β-hydroxysteroid dehydrogenase (HSD)
activity correlates inversely with levels of DHEA and DHEA-
sulfate.13 Human breast adipose catalyzes conversion of
androstenedione into testosterone, estrone, and estradiol.14
Hence, sex steroids influence lipid biology in a context-
dependent manner.
Apart from free (unconjugated) steroids, sex steroids also
occur conjugated with sulfate. Sulfotransferases catalyze sulfo-
conjugation using 3′-phospho-adenosine-5′-phosphosulfate as
cosubstrate, while steroid sulfatases (STS) liberate steroids
from their sulfates, increasing tissue concentrations. Interest-
ingly, steroid sulfation affects intermediary metabolism. High-
fat diet (HFD) induced metabolic phenotypes were
exacerbated when human STS was overexpressed in adipose
of male mice, possibly through increasing androgens.15 In
female mice, however, overexpression of STS ameliorated
steatosis caused by a HFD, possibly through increasing
estrogen. In contrast, liver STS overexpression reduced obesity
and type 2 diabetes in both male and female mice by affecting
estrogen and androgen concentrations, respectively.16
These data reveal a compelling relationship between sex
steroids and adiposity, signifying the importance of quantifying
multiple steroids in energy regulating tissues. Here we report
an assay based on high-performance liquid chromatography/
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tandem mass spectrometry (HPLC-MS/MS) to quantify T,
DHEA, E2 and their sulfates in serum, liver, BAT, inguinal
white adipose tissue (iWAT), epididymal white adipose tissue
(eWAT), and parametrial white adipose tissue (pmWAT) to
facilitate study of steroid functions. This assay is the first
HPLC-MS/MS method to quantify steroids in adipose tissues
and should contribute to the study of steroid functions in
energy balance and adipose biology.
■ EXPERIMENTAL SECTION
Materials. Optima LC/MS grade methanol, acetonitrile,
water, and formic acid were purchased from Fisher Scientific
(Pittsburgh, PA). Sulfatase (Type H-1, from Helix pomatia)
was purchased from Sigma-Aldrich (St. Louis, MO). Steroid
standards DHEA, E2, T, DHEA-d5, estradiol-d5, and
testosterone-d3 were purchased from Sigma-Aldrich. Steroid
standards were prepared on the day of use.
Animals and Tissues. C57BL/6J mice were purchased
from Jackson Laboratory (Bar Harbor, ME). Mice were fed an
AIN93G diet with 4 IU/g vitamin A (retinyl palmitate) for
more than 10 generations before analyses. A group of mice
(6−8 weeks old) was fed a HFD beginning 1 week prior to
euthanasia. At the onset of HFD feeding, female mice were
transferred to cages in which males had been housed to initiate
their estrus cycle. Serum, liver, eWAT or pmWAT, iWAT, and
BAT samples were snap-frozen in liquid nitrogen immediately
after harvest. Samples were stored at −80 °C until assay.
Animal experiments were performed in accordance with the
National Institutes of Health’s Guide for the Care and Use of
Laboratory Animals. Protocols were approved by the UC-
Berkeley Animal Care and Use Committee.
Extraction of Free Steroids. Tissue samples (∼100 mg
each) were placed into 2 mL round-bottom Eppendorf tubes
with a metal bead, along with 1.5 mL of acetonitrile and a 20
μL mixture of internal standards, including 100 nM DHEA-d5,
50 nM E2-d5, 50 nM T-d3 (IS mix) prepared in acetonitrile;
then the samples were homogenized with a TissueLyser II
(Qiagen, Germantown, MD) at 30/sec for 30 s. The
homogenate was stored for 30 min at −20 °C and then
centrifuged for 5 min at 12000 × g and at 4 °C. The
supernatant was transferred to a glass round-bottom tube and
evaporated under a N2 stream. The residue was resuspended in
2 mL of 0.2 M sodium acetate buffer (pH 5.0) and extracted
with 10 mL of hexane. The mixture was centrifuged for 2 min
at 1200 × g, and the upper hexane layer was transferred to a
new glass tube and evaporated under nitrogen with gentle
heating at 25−30 °C in a water bath (Model N-EVAP 112,
Organomation Associates, Berlin, MA). The residue was
reconstituted in 40 μL of methanol with vortexing. To remove
a small amount of white precipitate, the mixture was spun for
20 s at 1200 × g. The supernatant was transferred into an
autosampler vial insert with care not to include any solid
material. A total of 1 μL was injected for LC-APCI-MS/MS
analysis of unconjugated steroids.
Extraction of Conjugated Steroids. Conjugated steroids
were extracted from the remaining aqueous phase after
extraction of free steroids, and residual hexane was removed
by pipetting and a stream of N2. Sulfatase (100 μL of 10 mg/
mL in the acetate buffer) and 20 μL of IS mix were added to
the aqueous phase. The reaction was incubated overnight at 37
°C. Hydrolyzed steroids were extracted with 10 mL of hexane.
The hexane layer was evaporated under a stream of N2. The
residue was reconstituted in 40 μL of methanol.
HPLC. DHEA, E2, and T were separated via reverse-phase
chromatography with an Agilent 1290 system (Santa Clara,
CA, U.S.A.) equipped with a binary pump, column compart-
ment, and autosampler. The column compartment was
maintained at 40 °C: samples were kept in the autosampler
at 10 °C. Separation was achieved with an analytical Ascentis
Express RP-Amide column (100 × 2.1 mm, 2.7 μm, Sigma
Aldrich) at a flow rate of 0.4 mL/min. Mobile phases were (A)
0.1% formic acid in water; (B) 0.1% formic acid in methanol.
The following gradient was applied over a run time of 25 min:
0 to 2 min, 50% B; 2 to 8 min, 50 to 95% B; 8 to 20 min,
holding at 95% B; 20 to 23.5 min, 95 to 50% B; 23.5 to 25 min,
back to 50% B and re-equilibrating for 1.5 min.
MS/MS. Analytes were detected with a Sciex API-4000
triple-quadrupole mass spectrometer in positive atmospheric
pressure chemical ionization (APCI) mode. Analyst version 1.6
software controlled the instrument, which was operated in the
multiple reaction monitoring (MRM) mode. Mass transitions
to produce optimum sensitivity were determined by injecting 1
pmol standards as described in Table 1. Optimized MS
variables were: curtain gas, 10 psig; collision gas, 7 psig; ion
source gas 1, 70 psig; nebulizer current, 3 μA; source
temperature, 350 °C; declustering potential, 55 V; entrance
potential, 10 V; collision exit potential, 5 V. Optimized
collision energy values were 45, 20, and 25 eV for T, DHEA,
and E2, respectively.
Calibration Curve/Accuracy/LOQ/LOD. Calibration
curves were generated by serial dilutions of DHEA, E2, and
T standard mixture (3 repeats). Accuracy was determined by
dividing the area under the curve (AUC) of standards by the
slopes of calibration curves at 3 different concentrations (10/
100/1,000 fmol). The lower limit of quantification (LOQ) and
the lower limit of detection were defined as signal-to-noise
ratios of 10 and 3, respectively.
Precision/Recovery. To determine coefficients of variation
and recovery, ∼1.2 g of pooled samples (male liver, eWAT,
iWAT, or BAT), or serum (1.2 mL) were homogenized in 18
mL of acetonitrile. Then, 240 μL of IS mixture was added and
the resulting sample was divided into 12 aliquots, 6 of which
were assayed immediately for intra-assay variation. The other 6
aliquots were stored at −80 °C and assayed individually over 6
consecutive days to determine interassay variation. Recovery
was calculated using the 6 intra-assay samples per tissue type
by comparing AUCs of DHEA-d5, E2-d5, and T-d5 measured
in tissues with amounts quantified in pure IS in methanol,
which was not extracted.
Statistics. Results are expressed as mean ± SEM, unless
noted otherwise. Statistical analyses were made by two-tailed
unpaired t tests using GraphPad Prism 7 (San Diego, CA). To
Table 1. Mass Transitions and Collision Energies for Each
Analyte
mass transition
analyte
MW
(g/mol) Q1 (m/z)
Q3
(m/z)
CE
(eV)
T 288.42 289.3 [M + H]+ 97.3 45
T-d3 291.44 292.4 [M + H]+ 97.1 45
DHEA 288.42 271.2 [M + H − H2O]+ 213.1 20
DHEA-d5 293.46 276.4 [M + H − H2O]+ 218.5 20
E2 272.38 255.3 [M + H − H2O]+ 159.2 25
E2-d5 277.41 260.3 [M + H − H2O]+ 161.3 25
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prevent distortion of comparisons by missing data, values
below the LOD were plotted using the highest amount below
LOD (1, 1, and 2 fmol, respectively, for T, DHEA, and E2)
normalized by average tissue weight (or volume). p-Values
<0.05 were accepted as statistically significant.
■ RESULTS AND DISCUSSION
Extraction. Acetonitrile was chosen as homogenizing
solvent versus methanol and several combinations of
methanol/isopropanol. Although methanol extracted most
steroids efficiently from serum, liver, and BAT, E2, and E2-
d5 were recovered poorly from white adipose. This probably
was because E2 fractionated into the fat phase, based on the
log of its octanol/water partition coefficient (Kow = 4.01),
which is much higher than those of T (Kow = 3.32) and DHEA
(Kow = 3.23).
17 Homogenization in acetonitrile followed by
freezing separated E2 from precipitated lipids. To maximize
extraction efficiency, acetonitrile was replaced with acetate
buffer (pH 5.0), from which free steroids were extracted
efficiently into the hexane phase, whereas sulfated steroids
were retained in the aqueous phase. No steroids were detected
in the second hexane phase when samples were extracted with
hexane twice (data not shown). We diluted DHEA-S and E2-S
standards in acetate buffer and extracted them to test for
unintended hydrolysis. T-S standards are not available. DHEA
and E2 signals were not detected up to 200 pmol (data not
shown). Sulfatase activity was tested by comparing a
hydrolyzed DHEA-S standard with a free DHEA standard,
which showed 83−111% recovery (Table S1) and a linear (r2 =
0.9986) concentration−response (Figure S1).
Previous reports applied a combination of methanol and
water (7:3) or dimethoxymethane (4:1) to separate steroids
from lipids.13,18−20 Beĺanger et al., used a GC/MS although it
was not reported how it was validated. The other three studies
detected steroids using RIA. These studies did not report
recovery of E2 from white adipose tissue. Contemporary mass
spectrometry is coupled usually with reverse phase LC because
normal phase solvents can ignite in the MS source. It is critical
to remove as much lipid impurities as possible to prevent
compromising reverse-phase columns. Our extraction method
efficiently removed lipids and recovered steroids of interest.
LC-MS/MS. A water/methanol mixture with 0.1% formic
acid was superior for signal sensitivity compared to a water/
acetonitrile combination. Retention times with this methanol-
based phase were stable (±0.01 min) during a given analysis.
For MS analysis, APCI in positive mode was used because we
found it was better suited for analysis of these highly lipid-
soluble steroids. In APCI, a nebulized sample is ionized by
corona discharge, which provides relatively strong ionization,
suitable for compounds that do not readily form ions in
solution, whereas ESI produces ions through ion evaporation
that has greater sensitivity with polar analytes. Fragmentation
and MS/MS ion transitions for steroids were optimized for
maximum sensitivity. The fragmentation patterns of ionized
([M + H]+) or ionized and dehydrated ([M + H − H2O]+)
steroids are shown in Table 1.
Performance. Representative standard curves for each
analyte using LC-MS/MS had linear dynamic ranges from 2 to
1000 fmol (Figure 1). The best-fit curves were similar, even at
the low ends of the linear working ranges. LOQs of T, DHEA,
and E2 were 5, 10, and 10 fmol, respectively (Figure 2).
Accuracy values ranged between 95−102%, except for 10 fmol
DHEA (88%; Table 2).
Average recovery was 96%; coefficients of variation were
20% or lower (Table 3). The mobile phase gradient and
running time were optimized to separate interfering peaks from
analytes (Figure 3).
Figure 1. Representative calibration curves for (A, B) T; (C, D) DHEA; (E, F) E2. The y-axis shows the area of the peak (AUC) generated by the
MS transition of each steroid monitored by MS/MS. The x-axis shows the molar amount analyzed. Data did not deviate from linearity (r2 > 0.995)
over the tested ranges. Panels B, D, and F are enhancements of the lower ranges of A, C, and E, respectively. Each had slopes in the lower ranges
consistent with the slopes over the entire ranges. Data were fit by linear regression analysis. Each point represents three replicates.
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Application. T was detected in male serum, eWAT, iWAT,
and BAT, but not in liver (not shown) nor in female tissues
(Figure 4). The biological variation in T levels was
considerable, with a 50-fold difference in serum of mice fed
the LFD, but only a 9-fold range in mice fed the HFD. Levels
of free and sulfated T tended to be higher in serum of the
LFD-fed group than in the HFD-fed group, but differences
were not statistically significant. HFD-fed males, however, had
greater numbers of mice with serum-conjugated T below the
LOD. In contrast to serum, tissue levels of T and T-S were all
above the LOD. T-S levels correlated with free T levels (r2 =
0.76, p < 0.0001) and did not seem to vary with dietary fat
(Figure S2). Quantified values of T were not affected by the
nature of normalization (tissue weight vs protein amount;
Figure 4E,F).
Free and conjugated DHEA were detected in serum, liver,
BAT, and pmWAT (Figure 5A−D). At least 50% of females
had serum free and conjugated DHEA below the LOD. This
was also true for the liver. Female BAT DHEA-S levels were
markedly, but not significantly, higher than free DHEA (Figure
5C). DHEA-S was not detected in pmWAT, although free
DHEA values were mostly above the LOD (Figure 5D). In
males, free DHEA was detected only in iWAT and eWAT of
HFD-fed mice (Figure 5E,F), which suggests a role for DHEA
in early adipogenesis. Free and conjugated E2 were detected
only in serum and BAT of females (Figure 6A,B). E2-S levels
were significantly higher than free E2 in both dietary
Figure 2. Lower limit of quantification (LOQ) for each analyte.
Table 2. Accuracies Calculated at Three Different
Concentrationsa
amount (fmol)
standard 10 100 1000
T 99 ± 13% 96 ± 2% 101 ± 2%
DHEA 88 ± 13% 98 ± 4% 102 ± 7%
E2 102 ± 21% 95 ± 7% 102 ± 3%
aAll values are mean ± SD, 3 repeats.
Table 3. Recovery and Precisiona
CV (%)
tissue IS recovery (%) intra-assay interassay
liver T-d3 102 ± 13 13 5
DHEA-d5 96 ± 13 14 12
E2-d5 98 ± 12 12 16
eWAT T-d3 99 ± 10 10 7
DHEA-d5 100 ± 20 20 10
E2-d5 98 ± 6 6 14
iWAT T-d3 98 ± 15 15 18
DHEA-d5 102 ± 16 16 14
E2-d5 88 ± 14 16 17
BAT T-d3 99 ± 10 10 12
DHEA-d5 96 ± 18 19 13
E2-d5 92 ± 14 16 7
serum T-d3 103 ± 8 8 5
DHEA-d5 114 ± 8 7 9
E2-d5 94 ± 7 8 4
aAll values are mean ± SD, 6 repeats.
Figure 3. Representative MRM chromatograms of (A) T extracted
from eWAT; (B) DHEA extracted from liver; and (C) E2 extracted
from iWAT. Baselines of internal standards (red) of Td3, DHEAd5,
and E2d5 were offset by 50, 50, and 250 cps, respectively, to enhance
clarity.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.9b03759
Anal. Chem. 2019, 91, 14624−14630
14627
conditions. Feeding a HFD did not affect free E2 levels in
serum and BAT.
The HFD experiment was done to investigate the early
effects of high fat on mice in puberty. Juveniles may be
particularly prone to adverse effects of HFD, as evidenced by
the observation that the rate of weight gain increases until 10−
12 weeks of age.21 We chose 1 week HFD exposure,
postulating that steroid metabolism contributes to early
adipocyte hyperplasia. This timing was based on the
preadipocyte proliferation rate maximizing 1 week after
initiating a HFD, but decreasing to baseline level thereafter,
even as fat mass keeps increasing by hypertrophy.22
■ COMPARISON WITH PREVIOUS ASSAYS
To the best of our knowledge, the current assay is the only LC-
MS/MS method that reports quantification of steroids in
adipose tissues (Table 4). Sensitivity is high compared to other
assays that also do not rely on derivatization, despite the
Figure 4. Free and conjugated T levels in (A) serum; (B) BAT; (C) iWAT; and (D) eWAT from male mice fed a low-fat diet vs a HFD for 1 week.
Normalization to protein amount was compared to normalization with tissue weight in (E) iWAT and (F) eWAT. N = 5 (LFD) and 7 (HFD).
Figure 5. Free and conjugated DHEA levels in (A) serum; (B) liver; (C) BAT; (D) pmWAT (females); (E) iWAT; (F) eWAT (males; means ±
SEM, n = 6, females; n = 5, male LFD; n = 7, male HFD). Filled shapes, half-filled shapes, and open shapes indicate values over LOQ, values
between LOQ and LOD, and values below LOD, respectively.
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difficulty of extracting steroids from adipose. Given the rarity
of tissue data, it is worth noting that we have preliminary data
from female mouse bone marrow samples in which DHEA,
DHEA-S, and E2-S have been detected with values greater
than the LOQ.
■ CONCLUSION
The present study reports a straightforward and effective
extraction for steroids from diverse tissues, including adipose,
coupled with LC-MS/MS. Quantification of steroids in mouse
tissues exposed for one week to a HFD revealed novel findings:
(1) free DHEA was detected only in the HFD-fed group of
male iWAT and eWAT; (2) sulfated DHEA and E2 were
higher than free steroids in female BAT, in contrast to iWAT
and eWAT; (3) circulating E2-S was higher than E2, whereas
circulating DHEA-S and T-S were lower than their
unconjugated counterparts; (4) the HFD tended to marginally,
but not statistically significantly, lower T levels in all tissues.
■ ASSOCIATED CONTENT
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Table 4. Comparison of Current Assay with Published Sex Steroid Assaysa
reference method derivative analytes
LOD
(fmol)
LOQ
(fmol) intra-assay CV (%)
linear dynamic
range tissues species
current LC/APCI/MS2 - DHEA, E2, T 2, 3, 2 5, 10, 5 <20 to 1000 fmol serum,
liver,
adipose
mouse
Denver et al.,
20197
LC/MS2 MPPZ E2 and 7 others 0.77 1.6 7.6 to 1595 fmol plasma human
Lee et al., 201623 LC/MS2 - DHEA, E2, T,9
others
35, 14, 73 5.1, 4.0, 7.5 to 1000, 100, 50
ng/mL
serum human
Matysik et al.,
201724
LC/MS/HRMS - T, 7 others 4 1−11.5 serum human
McCulloch et al.,
20176
LC/FF/APPI/MS2 - E2, T, 5 others 3.7, 0.7 serum human
Schofield et al.,
201725
LC/MS2 - E2, T 2.4, 4.6 <20 6−600 pg/mL,
1−1170 ng/dL
serum human
Star-Weinstock et
al., 201226
LC/ESI/MS2 quaternary
aminooxy
T 0.7 <15 1−5000 pg/mL serum human
Ankarberg-
Lindgren et al.,
201827
GC/MS2 PFBBr,
PFBHA,
PFPA
E2, T, 3 others 0.05, 2.7 <9 serum human
Gaikwad, 201328 LC/MS2 - DHEA, E2, T,
and 98 others
87, 9, 9 <19.7, <19.7, <8.8 to 20 ng/μL breast human
aBlank spaces indicate that data are not available.
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